Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Illumina, ArcherDx Expand Partnership on NGS IVD Tests

Illumina, ArcherDx Expand Partnership on NGS IVD Tests

Dec 03, 2019
|
staff reporter

NEW YORK – ArcherDx today announced a non-exclusive partnership with Illumina to develop next-generation sequencing-based in vitro diagnostic tests. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Molecular Diagnostics

  1. FDA Issues Emergency Use Authorization for Viracor Eurofins Coronavirus LDT

  2. COVID-19 Testing Drives 80 Percent Growth in GenMark Diagnostics Preliminary Q1 Revenues

  3. BillionToOne Developing Coronavirus Dx Test Based on Sanger Sequencing

  4. Myriad Genetics Withdrawing FY2020 Financial Guidance Due to COVID-19 Pandemic

  5. With Sputum Test for SARS-CoV-2, MicroGen Dx Aims to Challenge Quest, LabCorp

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.